DiaMedica Therapeutics Inc. (DMAC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 373.97M |
| Enterprise Value | 358.56M |
| P/E Ratio | -8.99 |
| PEG Ratio | 2.09 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 9.1 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -9.27 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.83 |
| Return On Equity | -0.78 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -32.7M |
| Net Income | -32.77M |
| Diluted EPS | -0.7 |
Balance Sheet
| Total Cash | 43.5M |
| Total Cash/Share | 0.81 |
| Total Debt | 185,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 6.72 |
| Book Value Per Share | 0.71 |
Price History
| 52-Week Change | -11.13 |
| 52-Week High | 10.42 |
| 52-Week Low | 5.25 |
| Moving Average 50 Days | 6.88 |
| Moving Average 200 Days | 7.2 |
Statistics
| Average Volume | 190,129 |
| Shares Outstanding | 53.88M |
| % Held by Institutions | 23.32 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | November 15, 2018 |
AD
